Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 3,170.00 | |
50 mg | 10-14 weeks | $ 4,180.00 | |
100 mg | 10-14 weeks | $ 5,800.00 |
Description | MK-1220 is a novel Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure. |
Molecular Weight | 779.94 |
Formula | C40H53N5O9S |
CAS No. | 924270-31-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MK-1220 924270-31-5 MK 1220 MK1220 inhibitor inhibit